J
Joanna Renke
Researcher at University of Gdańsk
Publications - 46
Citations - 502
Joanna Renke is an academic researcher from University of Gdańsk. The author has contributed to research in topics: Cutaneous Mastocytosis & Systemic mastocytosis. The author has an hindex of 10, co-authored 44 publications receiving 409 citations. Previous affiliations of Joanna Renke include Gdańsk Medical University & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Protein carbonyl groups' content as a useful clinical marker of antioxidant barrier impairment in plasma of children with juvenile chronic arthritis.
TL;DR: Correlation between the carbonyl groups content and the activity or the type of JCA may allow use of carbonyls as a clinical marker of antioxidant barrier impairment in this group of patients.
Journal ArticleDOI
Clinical aspects of paediatric mastocytosis: a review of 101 cases.
TL;DR: Background Cutaneous mastocytosis (CM) is a typical presentation of mastocybosis in children, however, systemic mastocyTosis may also occur in children.
Journal ArticleDOI
Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis
Bartosz Wasag,Marek Niedoszytko,Anna M. Piskorz,Magdalena Lange,Joanna Renke,Ewa Jassem,Wojciech Biernat,Maria Debiec-Rychter,Janusz Limon +8 more
TL;DR: The hypothesis that not only KIT mutations but other additional genetic abnormalities are contributing to more advanced forms of the disease is supported.
Journal Article
Mastocytosis in childhood
Joanna Renke,Magdalena Lange +1 more
TL;DR: Although mastocytosis is regarded as a rare disease in the population, among patients of dermatologists it is much more common, and there is a chance that thanks to to popularisation of knowledge of this disease will be more frequently diagnosed and known better.
Journal ArticleDOI
Interleukin-13 promoter gene polymorphism-1112C/T is associated with the systemic form of mastocytosis
Bogusław Nedoszytko,Marek Niedoszytko,Magdalena Lange,J. J. Van Doormaal,Jolanta Gleń,Monika Zabłotna,Joanna Renke,A. Vales,F. Buljubasic,Ewa Jassem,Jadwiga Roszkiewicz,Peter Valent +11 more
TL;DR: Patients with systemic mastocytosis are at risk to develop disease progression or a nonMC‐lineage haematopoietic neoplasm and one factor may be cytokine regulation of MC progenitors.